Abstract Objective To evaluate the effect of bladder volume change on the doses to normal tissues in cervical cancer patients undergoing external three-dimensional conformal radiotherapy (3DRT) plus 3D conformal brachytherapy (3DCBT). Methods The study included 56 patients with cervical cancer who were admitted to our hospital from 2012 to 2013 and received radical external 3DRT and 3DCBT. During 3DCBT, the doses to 0.1, 1.0, and 2.0 cm3(D0.1 cm3, D1.0 cm3, and D2.0 cm3, respectively) for the rectum, small intestine, sigmoid colon, and bladder under different bladder filling status (empty, 50, 100, and 150 ml) were compared and analyzed by paired t-test. Results The rectum D0.1 cm3 with bladder volumes of 50 and 100 ml were significantly reduced compared with that with an empty bladder (P=0.000,0.000). The D0.1 cm3, D1.0 cm3, and D2.0 cm3 for the small intestine with bladder volumes of 50, 100, and 150 ml were significantly reduced compared with those with an empty bladder (P=0.008,0.000,0.000 and 0.000,0.000,0.000 or 0.000,0.000,0.000). The D0.1 cm3, D1.0 cm3, and D2.0 cm3 for the bladder with bladder volumes of 100 and 150 ml were significantly increased compared with those with an empty bladder (P=0.000,0.000 and 0.000,0.000 or 0.000,0.000). Conclusions The doses to the bladder and small intestine are influenced by different bladder filling status, but the doses to the rectum and sigmoid colon show no significant variation. The increase in bladder volume is helpful in reducing the dose to the small intestine. Without any change in the bladder dose, the bladder volume of 50 ml is more beneficial to reduce the dose to the small intestine than those of 100 and 150 ml.
Shi Dan,Zhao Zhipeng,He Mingyuan et al. Effect of bladder volume change on normal tissue doses in external 3DRT and 3D conformal brachytherapy for cervical cancer[J]. Chinese Journal of Radiation Oncology, 2015, 24(2): 159-162.
Shi Dan,Zhao Zhipeng,He Mingyuan et al. Effect of bladder volume change on normal tissue doses in external 3DRT and 3D conformal brachytherapy for cervical cancer[J]. Chinese Journal of Radiation Oncology, 2015, 24(2): 159-162.
[1]Kvale G, Heuch I, Ursin G. Reproductive factors and risk of cancer of the uterine corpus:a prospective study[J]. Cancer Res,1988,48(21):6217-6221. [2]Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix:a systematic review and meta-analysis[J]. Lancet,2001,358(9284):781-786. [3]Patidar AK, Kumar HS, Walke RV, et al. Evaluation of the response of concurrent high dose rate intracavitary brachytherapy with external beam radiotherapy in management of early stage carcinoma cervix[J]. J Obstet Gynaecol India,2012,62(5):562-565.DOI:10.1007/s13224-012-0209-x. [4]Hanks GE, Herring DF, Kramer S. Patterns of care outcome studies. Results of the national practice in cancer of the cervix[J]. Cancer,1983,51(5):959-967. [5]Logsdon MD, Eifel PJ. Figo ⅢB squamous cell carcinoma of the cervix:an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy[J]. Int J Radiat Oncol Biol Phys,1999,43(4):763-775. [6]Potter R, Kirisits C, Fidarova EF, et al. Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma[J]. Acta Oncol,2008,47(7):1325-1336.DOI:10.1080/02841860802282794. [7]Yamashita H, Nakagawa K, Okuma K, et al. Correlation between bladder volume and irradiated dose of small bowel in CT-based planning of intracavitary brachytherapy for cervical cancer[J]. Jpn J Clin Oncol,2012,42(4):302-308.DOI:10.1093/jjco/hyr203. [8]Pelloski CE, Palmer M, Chronowski GM, et al. Comparison between CT-based volumetric calculations and ICRU reference point estimates of radiation dose delivered to bladder and rectum during intracavitary radiotherapy of cervical cancer[J]. Int J Radiat Oncol Biol Phys,2005,62(1):131-137. [9]Kim RY, Shen S, Lin HY, et al. Effects of bladder distension on organs at risk in 3D image-based planning of intracavitary brachytherapy for cervical cancer[J]. Int J Raiat Oncol Biol Phys,2010, 76(2):485-489.DOI:10.1016/j.ijrobp. [10]Cengiz M, Gurdalli S, Selek U, et al. Effect of bladder distension on dose distribution of intracavitary brachytherapy for cervical cancer:three-dimensional computed tomography plan evaluation[J]. Int J Radiat Oncol Biol Phys,2008,70(2):464-468. [11]Haie-Meder C, P tter R, Van L, et al. Recommendations from Gynaecologiacal (GYN) GEC-ESTRO Working Group (I):concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV[J]. Radiother Oncol,2005,74(3):235-245. [12]P tter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from Gynaecologiacal (GYN) GEC-ESTRO Working Group (Ⅱ):concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and adpects of 3D image-based anatomy, radiation physics, radiobiology[J]. Radiother Oncol,2006,78(1):67-77. [13]Ju SG, Huh SJ, Shin JS, et al. Different effects of bladder distention on point A-based and 3D-conformal intracavitary brachytherapy planning for cervical cancer[J]. J Radiat Res,2013,54(2):349-356.DOI:10.1093/jrr/rrs091.
2015, Vol. 24 
